Alpine Immune Sciences, Inc. (NASDAQ: ALPN), is a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- orbest-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development.

Biotechnology

Health Care

Alpine Immune Sciences

Stephanie Wisdo

Stanford Peng

Rupert Davies

Andrew Sandler

Kelly Mumma, SPHR (she / her)

Devon Campbell

Thaedra Thullbery, CPA

Remy Durand

Gary Albert

The Leadership Team at Alpine Immune Sciences is responsible for setting strategic direction, driving innovation, overseeing research and development, and ensuring successful clinical and business operations. This team, comprising top executives and principal scientists, collaborates to advance the company's mission of developing innovative immunotherapies to treat autoimmune and inflammatory diseases, managing both internal projects and external partnerships with global biopharmaceutical companies.

Leadership Team

Research and Clinical Science

Clinical and Medical Operations

Leadership Team

About

Team members

Other teams at Alpine Immune Sciences

Research and Clinical Science

Clinical and Medical Operations